Many potentially effective drugs that have been discovered have either failed completely to be turned into patient viable medicines or become only partially effective medicines because of drug solubility or manufacturing processing limitations. At DisperSol, our mission is to use our proprietary KinetiSol® technology to make new and better medicines with these drugs to help patients.

TECHNOLOGY BENEFITS

Removing Barriers
for New Medicines

We have made drugs water soluble that were previously insoluble by every other manufacturing method tried.

Fast and Easy
Process

Our process typically takes less than 20 seconds to complete and fits in-line with normal tableting and encapsulation manufacturing lines.

Can Outperform Spray Drying & Melt Extrusion

Our ability to process novel, GRAS excipients that spray drying and melt extrusion can’t, allows for the creation of superior formulations.

Latest News & Publications

KinetiSol-Based Amorphous Solid Dispersions.


Amorphous Solid Dispersions: Theory and Practice (2014) - 3 citations


Go to Publication

 

New Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-soluble Drug Delivery – Part 1.


AAPS PharmSciTech (2015) - 2 citations


Go to Publication